Status:

COMPLETED

Prospective Low Dose CT for Total Shoulder Arthroplasty/Reverse Shoulder Arthroplasty

Lead Sponsor:

Duke University

Conditions:

Shoulder Arthroplasty

Eligibility:

All Genders

18+ years

Brief Summary

This study is a prospective, departmental funded study examining the outcomes of simulated Low Dose CT scans compared to Conventional Dose CT scans in patients who present to Duke University for total...

Detailed Description

The purpose of this study is to compare the use of a conventional dose computed tomography scan (C-CT) to a simulated low dose computed tomography scan (L-CT) for preoperative planning in patients who...

Eligibility Criteria

Inclusion

  • Subjects are planned to undergo total or reverse shoulder arthroplasty
  • Subject must be 18 years or older
  • Subjects who have capacity to give informed consent

Exclusion

  • Subjects who are pregnant
  • Subjects under the age of 18
  • Subjects who do not have the capacity to give informed consent.

Key Trial Info

Start Date :

November 21 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 19 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05350319

Start Date

November 21 2022

End Date

September 19 2023

Last Update

December 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University Medical Center

Durham, North Carolina, United States, 27701

Prospective Low Dose CT for Total Shoulder Arthroplasty/Reverse Shoulder Arthroplasty | DecenTrialz